National Bank of Canada
BLFS icon

National Bank of Canada’s BioLife Solutions BLFS Stock Holding History

National Bank of Canada’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42K Buy
+127
New +$2.81K ﹤0.01% 2591

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

National Bank of Canada's BLFS Position: Q1 2026 in Review

National Bank of Canada opened a new position in BioLife Solutions (BLFS) in Q1 2026: 127 shares worth $2.42K. The stake represents ﹤0.01% of the portfolio and ranks #2591 among its holdings.

187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • National Bank of Canada held 127 shares of BioLife Solutions worth $2.42K as of Q1 2026.
  • BioLife Solutions was a new National Bank of Canada position in Q1 2026.
  • BioLife Solutions made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2591 holding.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.